ProMIS Neurosciences creates novel intrabodies for ALS, frontotemporal dementia and other …

TORONTO and CAMBRIDGE, Mass., April 30, 2020 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), …

Link to Full Article: Read Here